Literature DB >> 2852690

Corticotropin-releasing factor and adrenal function in major depression.

D Nerozzi1, G Bersani, E Melia, A Magnani, I Antonozzi, G Frajese.   

Abstract

We investigated ACTH and cortisol responses after ovine CRF injection (1 microgram/kg one bolus) in a group of 11 drug-free patients suffering from major depression. When compared to sex- and age-matched normal controls, our depressed patients showed: Higher ACTH basal values (p less than 0.002); higher cortisol basal values (p less than 0.009); blunted ACTH response to oCRF administration (p less than 0.23); higher cortisol response to oCRF (p less than 0.001). Our data show that in depressed patients the feed-back mechanism is functionally intact at the pituitary level on one hand, while on the other, a hyperresponsiveness of adrenal cortex (even to minimal stimuli) seems to be present. Moreover, a hypersecretion of endogenous CRF in these patients seems to be likely.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852690     DOI: 10.1007/BF03350921

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.

Authors:  H M Schulte; G P Chrousos; P W Gold; J D Booth; E H Oldfield; G B Cutler; D L Loriaux
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

2.  Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression.

Authors:  F Holsboer; U Von Bardeleben; A Gerken; G K Stalla; O A Müller
Journal:  N Engl J Med       Date:  1984-10-25       Impact factor: 91.245

3.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

4.  Plasma adrenocorticotropin and cortisol responses to intravenous injection of corticotropin-releasing factor in the morning and evening.

Authors:  T Tsukada; Y Nakai; T Koh; S Tsujii; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

5.  Corticotropin releasing factor produces behavioural activation in rats.

Authors:  R E Sutton; G F Koob; M Le Moal; J Rivier; W Vale
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

6.  Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.

Authors:  G C Curtis; J Mendels
Journal:  Arch Gen Psychiatry       Date:  1976-09

7.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

8.  The effects of corticotropin releasing factor on the anterior pituitary function of stalk-sectioned cynomolgus macaques: dose response of cortisol secretion.

Authors:  H M Schulte; G P Chrousos; E H Oldfield; P W Gold; G B Cutler; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1982-10       Impact factor: 5.958

9.  Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency.

Authors:  P W Gold; G P Chrousos
Journal:  Psychoneuroendocrinology       Date:  1985       Impact factor: 4.905

10.  Cosyntropin (ACTH alpha 1-24) stimulation test in depressed patients and healthy subjects.

Authors:  J D Amsterdam; A Winokur; E Abelman; I Lucki; K Rickels
Journal:  Am J Psychiatry       Date:  1983-07       Impact factor: 18.112

View more
  1 in total

1.  Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.

Authors:  G P Bernini; G F Argenio; F Cerri; F Franchi
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.